TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
AVLN

Avalyn Pharma Inc.

Healthcare · Biotechnology

28.40$ +1.0% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement AVLN
Line item Q1 25 Q2 25 Q1 26 Q2 26
– – – –
– – – –
– – – –
– +16.7% +28.0% +8.0%
– +14.7% +28.9% +30.7%
– +16.4% +28.2% +11.7%
– – – –
– – – +177.6%
– – – –
– – – –
– – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?